First Pacific Advisors, LP has added 214,705 shares of $BIO to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BIO.
BIO-RAD LABORATORIES Hedge Fund Activity
We have seen 197 institutional investors add shares of BIO-RAD LABORATORIES stock to their portfolio, and 230 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEALTHFRONT ADVISERS LLC removed 1,043,153 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $254,070,344
- VAN ECK ASSOCIATES CORP removed 580,281 shares (-44.5%) from their portfolio in Q4 2024, for an estimated $190,628,111
- BANK OF AMERICA CORP /DE/ added 374,269 shares (+705.9%) to their portfolio in Q4 2024, for an estimated $122,951,109
- SELECT EQUITY GROUP, L.P. removed 247,794 shares (-35.0%) from their portfolio in Q4 2024, for an estimated $81,402,806
- FIRST PACIFIC ADVISORS, LP added 214,705 shares (+136.0%) to their portfolio in Q1 2025, for an estimated $52,293,549
- MILLENNIUM MANAGEMENT LLC removed 204,723 shares (-35.1%) from their portfolio in Q4 2024, for an estimated $67,253,552
- ARIEL INVESTMENTS, LLC added 181,829 shares (+48.0%) to their portfolio in Q4 2024, for an estimated $59,732,644
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIO-RAD LABORATORIES Government Contracts
We have seen $5,231,647 of award payments to $BIO over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- DIAGNOSTIC TESTING: $717,635
- EVOLIS ANALYZER LEASE AND SERVICE: $349,878
- LYPHOCHEK WHOLE BLOOD METALS CONTROL - QUALITY CONTROL REAGENTS: $279,038
- REAGENTS USED IN BIO-RAD LAB, CHEMISTRY SECTION FOR THE PATHOLOGY DEPARTMENT.: $275,585
- CONSUMABLES: $259,470
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BIO-RAD LABORATORIES Analyst Ratings
Wall Street analysts have issued reports on $BIO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for BIO-RAD LABORATORIES, check out Quiver Quantitative's $BIO forecast page.
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BIO ticker page for more data.
